The store will not work correctly when cookies are disabled.
2-(6-(4-chlorophenylsulfonamido)-5,6,7,8-tetrahydronaphthalen-1-yl)acetic acid
ID: ALA3335473
PubChem CID: 118714499
Max Phase: Preclinical
Molecular Formula: C18H18ClNO4S
Molecular Weight: 379.87
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2
Standard InChI: InChI=1S/C18H18ClNO4S/c19-14-4-7-16(8-5-14)25(23,24)20-15-6-9-17-12(10-15)2-1-3-13(17)11-18(21)22/h1-5,7-8,15,20H,6,9-11H2,(H,21,22)
Standard InChI Key: XMIGWECSZMISCA-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
2.9014 -1.8696 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4970 -1.1639 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.0880 -1.8670 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9126 -1.1598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9126 -1.9769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6179 -2.3814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6179 -0.7470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3232 -1.1598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3216 -1.9751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0258 -2.3824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7321 -1.9755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7297 -1.1570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0249 -0.7534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2037 -0.7532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7883 -0.7574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7899 0.0650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0818 0.4675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3743 0.0610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3793 -0.7669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0880 -1.1696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3417 0.4644 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.0251 -3.1996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7325 -3.6088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7325 -4.4270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4412 -3.2018 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
4 7 1 0
5 6 1 0
6 9 1 0
8 7 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
4 14 1 0
14 2 1 0
2 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
10 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.87 | Molecular Weight (Monoisotopic): 379.0645 | AlogP: 2.80 | #Rotatable Bonds: 5 |
Polar Surface Area: 83.47 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.74 | CX Basic pKa: ┄ | CX LogP: 3.60 | CX LogD: 0.31 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.84 | Np Likeness Score: -0.78 |
References
1. Wang X, Liu L, Huang L, Herbst-Robinson K, Cornec AS, James MJ, Sugiyama S, Bassetto M, Brancale A, Trojanowski JQ, Lee VM, Smith AB, Brunden KR, Ballatore C.. (2014) Potent, long-acting cyclopentane-1,3-Dione thromboxane (A2)-receptor antagonists., 5 (9): [PMID:25221659] [10.1021/ml5002085] |